Proposed modifications and incorporation of plasma Epstein-Barr virus DNA improve the TNM staging system for Epstein-Barr virus-related nasopharyngeal carcinoma.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Works matching AU Tang, Ling-Long
Results: 78
1
2
Causal relationship between genetically predicted depression and cancer risk: a two-sample bi-directional mendelian randomization.
- Published in:
- 2022
- By:
- Publication type:
- journal article
3
Unraveling tumour microenvironment heterogeneity in nasopharyngeal carcinoma identifies biologically distinct immune subtypes predicting prognosis and immunotherapy responses.
- Published in:
- 2021
- By:
- Publication type:
- Letter
4
Transcription factor ATMIN facilitates chemoresistance in nasopharyngeal carcinoma.
- Published in:
- Cell Death & Disease, 2024, v. 15, n. 2, p. 1, doi. 10.1038/s41419-024-06496-x
- By:
- Publication type:
- Article
5
Treatment effects of cumulative cisplatin dose during radiotherapy following induction chemotherapy in nasopharyngeal carcinoma: propensity score analyses.
- Published in:
- Therapeutic Advances in Medical Oncology, 2020, v. 12, p. 1, doi. 10.1177/1758835920937424
- By:
- Publication type:
- Article
6
An integrated model of the gross tumor volume of cervical lymph nodes and pretreatment plasma Epstein–Barr virus DNA predicts survival of nasopharyngeal carcinoma in the intensity-modulated radiotherapy era: a big-data intelligence platform-based analysis
- Published in:
- Therapeutic Advances in Medical Oncology, 2019, v. 11, p. 1, doi. 10.1177/1758835919877729
- By:
- Publication type:
- Article
7
Selection and validation of chemotherapy beneficiaries among elderly nasopharyngeal carcinoma (NPC) patients treated with intensity-modulated radiation therapy (IMRT): a large real-world study.
- Published in:
- Radiation Oncology, 2022, v. 17, n. 1, p. 1, doi. 10.1186/s13014-022-02095-2
- By:
- Publication type:
- Article
8
Value of the prognostic nutritional index and weight loss in predicting metastasis and long-term mortality in nasopharyngeal carcinoma.
- Published in:
- 2015
- By:
- Publication type:
- journal article
9
Correction to: ARNTL hypermethylation promotes tumorigenesis and inhibits cisplatin sensitivity by activating CDK5 transcription in nasopharyngeal carcinoma.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
10
Neoadjuvant and Concurrent Chemotherapy Have Varied Impacts on the Prognosis of Patients with the Ascending and Descending Types of Nasopharyngeal Carcinoma Treated with Intensity-Modulated Radiotherapy.
- Published in:
- PLoS ONE, 2016, v. 11, n. 10, p. 1, doi. 10.1371/journal.pone.0161878
- By:
- Publication type:
- Article
11
Use of pretreatment serum uric acid level to predict metastasis in locally advanced nasopharyngeal carcinoma.
- Published in:
- Head & Neck, 2017, v. 39, n. 3, p. 492, doi. 10.1002/hed.24631
- By:
- Publication type:
- Article
12
Reduction of clinical target volume in patients with lateralized cancer of the nasopharynx and without contralateral lymph node metastasis receiving intensity-modulated radiotherapy.
- Published in:
- Head & Neck, 2016, v. 38, p. E468, doi. 10.1002/hed.24020
- By:
- Publication type:
- Article
13
Treatment outcomes and feasibility of partial neck irradiation for patients with nasopharyngeal carcinoma with only retropharyngeal lymph node metastasis after intensity-modulated radiotherapy.
- Published in:
- Head & Neck, 2014, v. 36, n. 4, p. 468, doi. 10.1002/hed.23314
- By:
- Publication type:
- Article
14
Grading of MRI-detected skull-base invasion in nasopharyngeal carcinoma and its prognostic value.
- Published in:
- Head & Neck, 2011, v. 33, n. 9, p. 1309, doi. 10.1002/hed.21606
- By:
- Publication type:
- Article
15
Association of delayed chemoradiotherapy with elevated Epstein-Barr virus DNA load and adverse clinical outcome in nasopharyngeal carcinoma treatment during the COVID-19 pandemic: a retrospective study.
- Published in:
- Cancer Cell International, 2022, v. 22, n. 1, p. 1, doi. 10.1186/s12935-022-02748-y
- By:
- Publication type:
- Article
16
Evolving landscape and academic attitudes toward the controversies of global immuno‐oncology trials.
- Published in:
- International Journal of Cancer, 2021, v. 149, n. 1, p. 108, doi. 10.1002/ijc.33503
- By:
- Publication type:
- Article
17
Hepatitis B virus screening and reactivation and management of patients with nasopharyngeal carcinoma: A large-scale, big-data intelligence platform-based analysis from an endemic area.
- Published in:
- Cancer (0008543X), 2017, v. 123, n. 18, p. 3540, doi. 10.1002/cncr.30775
- By:
- Publication type:
- Article
18
Prognostic value of chronic hepatitis B virus infection in patients with nasopharyngeal carcinoma: Analysis of 1301 patients from an endemic area in China.
- Published in:
- Cancer (0008543X), 2014, v. 120, n. 1, p. 68, doi. 10.1002/cncr.28377
- By:
- Publication type:
- Article
19
Progress report of a randomized trial comparing long-term survival and late toxicity of concurrent chemoradiotherapy with adjuvant chemotherapy versus radiotherapy alone in patients with stage III to IVB nasopharyngeal carcinoma from endemic regions of China
- Published in:
- Cancer (0008543X), 2013, v. 119, n. 12, p. 2230, doi. 10.1002/cncr.28049
- By:
- Publication type:
- Article
20
Prognostic value of pre-treatment [<sup>18</sup>F] FDG PET/CT in recurrent nasopharyngeal carcinoma without distant metastasis.
- Published in:
- BMC Cancer, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12885-024-12276-9
- By:
- Publication type:
- Article
21
FNDC3B 3′‐UTR shortening escapes from microRNA‐mediated gene repression and promotes nasopharyngeal carcinoma progression.
- Published in:
- Cancer Science, 2020, v. 111, n. 6, p. 1991, doi. 10.1111/cas.14394
- By:
- Publication type:
- Article
22
Prognostic value of nutritional risk screening 2002 scale in nasopharyngeal carcinoma: A large‐scale cohort study.
- Published in:
- Cancer Science, 2018, v. 109, n. 6, p. 1909, doi. 10.1111/cas.13603
- By:
- Publication type:
- Article
23
Anti-epidermal growth factor receptor therapy concurrently with induction chemotherapy in locoregionally advanced nasopharyngeal carcinoma.
- Published in:
- Cancer Science, 2018, v. 109, n. 5, p. 1609, doi. 10.1111/cas.13589
- By:
- Publication type:
- Article
24
Optimal cumulative cisplatin dose in nasopharyngeal carcinoma patients receiving additional induction chemotherapy.
- Published in:
- Cancer Science, 2018, v. 109, n. 3, p. 751, doi. 10.1111/cas.13474
- By:
- Publication type:
- Article
25
Socioeconomic factors and survival in patients with non-metastatic head and neck squamous cell carcinoma.
- Published in:
- Cancer Science, 2017, v. 108, n. 6, p. 1253, doi. 10.1111/cas.13250
- By:
- Publication type:
- Article
26
DCAF7 Acts as A Scaffold to Recruit USP10 for G3BP1 Deubiquitylation and Facilitates Chemoresistance and Metastasis in Nasopharyngeal Carcinoma.
- Published in:
- Advanced Science, 2024, v. 11, n. 36, p. 1, doi. 10.1002/advs.202403262
- By:
- Publication type:
- Article
27
DCAF7 Acts as A Scaffold to Recruit USP10 for G3BP1 Deubiquitylation and Facilitates Chemoresistance and Metastasis in Nasopharyngeal Carcinoma (Adv. Sci. 36/2024).
- Published in:
- Advanced Science, 2024, v. 11, n. 36, p. 1, doi. 10.1002/advs.202470217
- By:
- Publication type:
- Article
28
Prognostic value of MRI‐determined cervical lymph node size in nasopharyngeal carcinoma.
- Published in:
- Cancer Medicine, 2020, v. 9, n. 19, p. 7100, doi. 10.1002/cam4.3392
- By:
- Publication type:
- Article
29
Thyroid dose‐volume thresholds for the risk of radiation‐related hypothyroidism in nasopharyngeal carcinoma treated with intensity‐modulated radiotherapy—A single‐institution study.
- Published in:
- Cancer Medicine, 2019, v. 8, n. 16, p. 6887, doi. 10.1002/cam4.2574
- By:
- Publication type:
- Article
30
The development and external validation of simplified T category classification for nasopharyngeal carcinoma to improve the prognostic value in the intensity‐modulated radiotherapy era.
- Published in:
- Cancer Medicine, 2019, v. 8, n. 5, p. 2213, doi. 10.1002/cam4.2131
- By:
- Publication type:
- Article
31
Relationship between pretreatment concentration of plasma Epstein‐Barr virus DNA and tumor burden in nasopharyngeal carcinoma: An updated interpretation.
- Published in:
- Cancer Medicine, 2018, v. 7, n. 12, p. 5988, doi. 10.1002/cam4.1858
- By:
- Publication type:
- Article
32
Impact of marital status at diagnosis on survival and its change over time between 1973 and 2012 in patients with nasopharyngeal carcinoma: a propensity score-matched analysis.
- Published in:
- Cancer Medicine, 2017, v. 6, n. 12, p. 3040, doi. 10.1002/cam4.1232
- By:
- Publication type:
- Article
33
Combined prognostic value of pretreatment anemia and cervical node necrosis in patients with nasopharyngeal carcinoma receiving intensity-modulated radiotherapy: A large-scale retrospective study.
- Published in:
- Cancer Medicine, 2017, v. 6, n. 12, p. 2822, doi. 10.1002/cam4.1233
- By:
- Publication type:
- Article
34
The current status of clinical trials focusing on nasopharyngeal carcinoma: A comprehensive analysis of ClinicalTrials.gov database.
- Published in:
- PLoS ONE, 2018, v. 13, n. 5, p. 1, doi. 10.1371/journal.pone.0196730
- By:
- Publication type:
- Article
35
Low BRMS1 expression promotes nasopharyngeal carcinoma metastasis in vitro and in vivo and is associated with poor patient survival.
- Published in:
- BMC Cancer, 2012, v. 12, n. 1, p. 376, doi. 10.1186/1471-2407-12-376
- By:
- Publication type:
- Article
36
Nasopharyngeal carcinoma treated with intensity-modulated radiotherapy: clinical outcomes and patterns of failure among subsets of 8th AJCC stage IVa.
- Published in:
- 2020
- By:
- Publication type:
- journal article
37
Refining the Role of Lymph Node Biopsy in Survival for Patients with Nasopharyngeal Carcinoma: Population-Based Study from the Surveillance Epidemiology and End-Results Registry.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2017, v. 24, n. 9, p. 2580, doi. 10.1245/s10434-017-5966-4
- By:
- Publication type:
- Article
38
Correction: Survival-related indicators ALOX12B and SPRR1A are associated with DNA damage repair and tumor microenvironment status in HPV 16-negative head and neck squamous cell carcinoma patients.
- Published in:
- 2022
- By:
- Publication type:
- corrected article
39
Survival-related indicators ALOX12B and SPRR1A are associated with DNA damage repair and tumor microenvironment status in HPV 16-negative head and neck squamous cell carcinoma patients.
- Published in:
- BMC Cancer, 2022, v. 22, n. 1, p. 1, doi. 10.1186/s12885-022-09722-x
- By:
- Publication type:
- Article
40
Survival-related indicators ALOX12B and SPRR1A are associated with DNA damage repair and tumor microenvironment status in HPV 16-negative head and neck squamous cell carcinoma patients.
- Published in:
- 2022
- By:
- Publication type:
- journal article
41
Disparities in positive results and dissemination of randomized controlled trials in immuno-oncology.
- Published in:
- International Reviews of Immunology, 2023, v. 42, n. 2, p. 91, doi. 10.1080/08830185.2022.2088744
- By:
- Publication type:
- Article
42
Selection and Validation of Induction Chemotherapy Beneficiaries Among Patients With T3N0, T3N1, T4N0 Nasopharyngeal Carcinoma Using Epstein-Barr Virus DNA: A Joint Analysis of Real-World and Clinical Trial Data.
- Published in:
- Frontiers in Oncology, 2019, v. 9, p. 1, doi. 10.3389/fonc.2019.01343
- By:
- Publication type:
- Article
43
The Chinese Society of Clinical Oncology (CSCO) clinical guidelines for the diagnosis and treatment of nasopharyngeal carcinoma.
- Published in:
- Cancer Communications, 2021, v. 41, n. 11, p. 1195, doi. 10.1002/cac2.12218
- By:
- Publication type:
- Article
44
Patterns and prognosis of regional recurrence in nasopharyngeal carcinoma after intensity‐modulated radiotherapy.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 2, p. 1399, doi. 10.1002/cam4.5020
- By:
- Publication type:
- Article
45
The immune modulation effects of gemcitabine plus cisplatin induction chemotherapy in nasopharyngeal carcinoma.
- Published in:
- Cancer Medicine, 2022, v. 11, n. 18, p. 3437, doi. 10.1002/cam4.4705
- By:
- Publication type:
- Article
46
Dose-volume relationships for moderate or severe neck muscle atrophy after intensity-modulated radiotherapy in patients with nasopharyngeal carcinoma.
- Published in:
- Scientific Reports, 2015, p. 18415, doi. 10.1038/srep18415
- By:
- Publication type:
- Article
47
Neoadjuvant chemotherapy in locally advanced nasopharyngeal carcinoma: Defining high-risk patients who may benefit before concurrent chemotherapy combined with intensity-modulated radiotherapy.
- Published in:
- Scientific Reports, 2015, p. 16664, doi. 10.1038/srep16664
- By:
- Publication type:
- Article
48
Dose-volume factors associated with ear disorders following intensity modulated radiotherapy in nasopharyngeal carcinoma.
- Published in:
- Scientific Reports, 2015, p. 13525, doi. 10.1038/srep13525
- By:
- Publication type:
- Article
49
Potential surrogate endpoints for overall survival in locoregionally advanced nasopharyngeal carcinoma: an analysis of a phase III randomized trial.
- Published in:
- Scientific Reports, 2015, p. 12502, doi. 10.1038/srep12502
- By:
- Publication type:
- Article
50
A Nomogram Based on Serum Biomarkers and Clinical Characteristics to Predict Survival in Patients With Non-Metastatic Nasopharyngeal Carcinoma.
- Published in:
- Frontiers in Oncology, 2020, v. 10, p. N.PAG, doi. 10.3389/fonc.2020.594363
- By:
- Publication type:
- Article